Cumberland Pharmaceuticals (CPIX) Price to Book (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Price to Book across 17 years of filings, most recently posting 1.87 for Q2 2026.

• In Q2 2026, Price to Book rose 3.5% year-over-year to 1.87; the TTM figure through Jun 2026 stood at 1.87 (up 3.5% YoY), while the FY2025 annual figure was 1.15, down 21.47% from the prior year.
• Price to Book came in at 1.87 for Q2 2026 at Cumberland Pharmaceuticals, down from 2.29 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 2.29 in Q1 2026 to a low of 0.57 in Q2 2023.
• Average Price to Book over 5 years is 1.15, with a median of 0.9 recorded in 2022.
• Year-over-year, Price to Book tumbled 44.4% in 2022 and surged 155.23% in 2025.
• Over 5 years, Price to Book stood at 0.9 in 2022, then retreated by 3.85% to 0.86 in 2023, then jumped by 69.77% to 1.47 in 2024, then dropped by 21.47% to 1.15 in 2025, then soared by 62.71% to 1.87 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 1.87 in Q2 2026, 2.29 in Q1 2026, and 1.15 in Q4 2025.